Semra Yetiş

Recent publications · Crossref

5 total works indexed

1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

   · 2020 · cited 2,250x

2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

   · 2020 · cited 1,840x

3. Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

   · 2005 · cited 767x

4. Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology

   · 2008 · cited 727x

5. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

   · 2021 · cited 689x

via Crossref · CC0